Randomized Phase 2 With CpG-ODN in Malignant Glioblastoma

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Assistance Publique - Hôpitaux de Paris

ClinicalTrials.gov Identifier:

NCT00190424

First received: September 14, 2005

Last updated: December 12, 2012

Last verified: September 2005

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2010
Primary Completion Date:	October 2008 (Final data collection date for primary outcome measure)